688046 药康生物
2026/06 - 中期
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资78,060-12.11%88,81280,04369,19868,536
投资性房地产0--0000
固定资产562,693-1.84%573,247493,222486,699194,079
在建工程29,46031.16%22,46190,85289,603171,670
无形资产68,588-3.90%71,37249,04647,34148,514
商誉0--0000
其他非流动资产398,42611.38%357,702149,709227,226303,907
1,137,2282.12%1,113,593862,871920,067786,706

流动资产
货币资金323,104-33.60%486,621701,372560,166421,708
应收账款422,5229.76%384,962350,806269,390185,216
存货95,87831.41%72,96154,19747,09249,471
其他流动资产860,3476.62%806,930603,399780,875810,616
1,701,851-2.83%1,751,4741,709,7741,657,5231,467,010

流动负债
短期借款138,463-26.08%187,32588,04076,15712,206
应付票据0--0000
应付帐款74,2418.96%68,13472,175101,86050,787
其他流动负债256,430-5.61%271,685210,980188,392151,077
469,134-11.00%527,144371,196366,409214,070
流动资产净值1,232,7170.69%1,224,3301,338,5781,291,1141,252,940
资产总额减流动负债2,369,9461.37%2,337,9232,201,4502,211,1812,039,647

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债103,563-6.47%110,72666,72386,52461,933
103,563-6.47%110,72666,72386,52461,933

总权益
    实收股本410,0000.00%410,000410,000410,000410,000
    储备项目1,856,3832.16%1,817,1971,724,7261,714,6561,567,714
股东权益2,266,3831.76%2,227,1972,134,7262,124,6561,977,714
非控股权益0--0000